Ledger.Open graph →
SEC Form D · Amendment · filed November 19, 2013

Vascular Pharmaceuticals, Inc

Offering
$16.0M
Sold
$9.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CHAPEL HILL, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Nicolas Chaillan · New York, NYDirectorCarl Serger · Gaithersburg, MDDirectorVaughn Kailian · Chapel Hill, NCDirectorSatish D. Dharmaraj · Menlo Park, CAExec · DirectorWilliam D. Price · Bozeman, MTDirectorAnthony Limbrick · Dublin, IrelandExec · DirectorJason Eaglestone · Dublin, IrelandDirectorEric Teller · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗